Nicotine Dependence Clinical Trial
Official title:
Phase 1 Study of Family Consultation for Change-Resistant Smokers
Although spousal support predicts the success of a smoker's cessation efforts, "social support" interventions based on teaching partners better support skills have had consistently disappointing results. We examined the potential utility of a family-consultation (FAMCON) intervention based on family-systems theory in a treatment-development project involving 20 couples in which one partner (the primary smoker) continued to smoke despite having or being at significant risk for heart or lung disease. Results were promising. The 50% rate of stable abstinence achieved by primary smokers over at least 6 months exceeds benchmark success rates reported in the literature for other, comparably intensive interventions, suggesting that a couple-focused intervention different in concept and format from social-support interventions tested in the past may hold promise for health-compromised smokers. The FAMCON approach appeared particularly well-suited to female smokers and smokers whose partner also smoked – two sub-groups at high risk for relapse.
Although spousal support predicts the success of a smoker's cessation efforts, "social
support" interventions based on teaching partners better support skills have had
consistently disappointing results. In this Stage I (treatment development) study we
examined the potential utility of a family-consultation (FAMCON) intervention based on
family-systems theory.
Specifically, in this Phase-I study we developed, standardized, and pilot tested a systemic,
couple-focused treatment for change-resistant smokers based on the assumption that a
smoker's marital and family relationships play a key role in whether he or she continues to
smoke.
The intervention provides up to 10 sessions of “family consultation” over 2-5 months to
single- or dual-smoker couples in which at least one partner continued to smoke despite
having lung disease, heart disease, or multiple cardiac risk factors.
The treatment focuses on the immediate social context of smoking, aiming both to interrupt
well-intended “solutions” that ironically feed back to keep smoking going, and to help
clients realign important relationships in ways not organized around tobacco use.
Participants were 20 couples in which one partner (the primary smoker) continued to smoke
despite having or being at significant risk for heart or lung disease.
Results are promising. The 50% rate of stable abstinence achieved by primary smokers over 6
months (with 63% abstinence rates for secondary smokers) exceeds benchmark success rates
reported in the literature for other, comparably intensive interventions, suggesting that a
couple-focused intervention different in concept and format from social-support
interventions tested in the past may hold promise for health-compromised smokers.
The12-month cessation rates were 40% for primary smokers and 63% for secondary smokers.
The FAMCON approach appeared particularly well-suited to female smokers and smokers whose
partner also smoked – two sub-groups at high risk for relapse.
References:
Rohrbaugh, M.J., Shoham, V., Trost, S., Muramoto, M., Cate, R., & Leischow, S. (2001).
Couple-dynamics of change resistant smoking: Toward a family-consultation model. Family
Process, 40, 15 – 31.
Shoham, V., Rohrbaugh, M.J., Trost, S.E., & Muramoto, M. (in press). A family consultation
(FAMCON) intervention for health-compromised smokers. Journal of Substance Abuse Treatment.
;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05176418 -
IV Pulsed-Nicotine as a Model of Smoking: The Effects of Dose and Delivery Rate
|
Early Phase 1 | |
Completed |
NCT04084210 -
Impact of Alternative Nicotine-Delivery Products on Combustible Cigarette Use
|
Phase 2 | |
Completed |
NCT04043728 -
Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study
|
N/A | |
Withdrawn |
NCT03707600 -
State and Trait Mediated Response to TMS in Substance Use Disorder
|
N/A | |
Recruiting |
NCT03999099 -
Targeting Orexin to Treat Nicotine Dependence
|
Phase 1 | |
Completed |
NCT03847155 -
Prevention of Nicotine Abstinence in Critically Ill Patients After Major Surgery
|
N/A | |
Completed |
NCT02840435 -
Study on Sit to Quit Phone Intervention
|
N/A | |
Completed |
NCT02139930 -
Project 2: Strategies for Reducing Nicotine Content in Cigarettes
|
N/A | |
Completed |
NCT01982110 -
A Mindfulness Based Application for Smoking Cessation
|
N/A | |
Completed |
NCT01926626 -
Evaluation of Moclobemide, a Reversible MAO-A Inhibitor, as an Adjunct to Nicotine Replacement Therapy in Female Smokers
|
Phase 2 | |
Completed |
NCT01569490 -
Striving to Quit: First Breath
|
N/A | |
Withdrawn |
NCT01569477 -
Striving to Quit-Wisconsin Tobacco Quit Line
|
N/A | |
Completed |
NCT01685996 -
Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation
|
Phase 1/Phase 2 | |
Completed |
NCT01632189 -
The Effect of Varenicline on D2/D3 Receptor Binding in Smokers
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT00996034 -
Nicotine Vaccination and Nicotinic Receptor Occupancy
|
Phase 2 | |
Completed |
NCT01061528 -
Coping Skills Treatment for Smoking Cessation
|
N/A | |
Suspended |
NCT01636336 -
Effects of Progesterone on Smoked Nicotine Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effects
|
N/A | |
Withdrawn |
NCT01589081 -
Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect
|
N/A | |
Completed |
NCT01943994 -
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
|
N/A |